Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

PPH
VanEck Vectors Pharmaceutical ETF

  • Fund Description

    VanEck Vectors Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 02/21/17

    • 30-Day SEC Yield1

      2.12%
    • Total Net Assets

      $301.9M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      03/31/2017
  • Portfolio Composition (%)
    as of 02/21/17

    • % of Net Assets
    • Stocks

      100.06
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.06
  • Download All HoldingsDaily Holdings (%) as of 02/21/17

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Johnson & Johnson
    JNJ US
    256,321
    30,671,37110.16
    Novartis Ag
    NVS US
    301,830
    23,252,9837.70
    Pfizer Inc
    PFE US
    606,567
    20,392,7836.76
    Abbott Laboratories
    ABT US
    383,144
    17,245,3115.71
    Merck & Co Inc
    MRK US
    237,586
    15,557,1315.15
    Glaxosmithkline Plc
    GSK US
    365,640
    15,221,5935.04
    Eli Lilly & Co
    LLY US
    183,397
    14,737,7834.88
    Sanofi
    SNY US
    338,843
    14,488,9274.80
    Abbvie Inc
    ABBV US
    228,868
    14,150,9084.69
    Astrazeneca Plc
    AZN US
    478,012
    13,867,1284.59
    Bristol-Myers Squibb Co
    BMY US
    248,532
    13,614,5834.51
    Shire Plc
    SHPG US
    74,975
    13,544,2344.49
    Mckesson Corp
    MCK US
    87,268
    13,167,8694.36
    Zoetis Inc
    ZTS US
    241,063
    12,889,6394.27
    Teva Pharmaceutical Industries Ltd
    TEVA US
    350,325
    12,839,4114.25
    Mylan Nv
    MYL US
    293,848
    12,429,7704.12
    Novo Nordisk A/S
    NVO US
    351,042
    12,416,3564.11
    Amerisourcebergen Corp
    ABC US
    105,749
    9,624,2163.19
    Perrigo Co Plc
    PRGO US
    88,584
    7,500,4072.48
    Valeant Pharmaceuticals International I
    VRX US
    229,003
    3,755,6491.24
    Jazz Pharmaceuticals Plc
    JAZZ US
    27,390
    3,723,1231.23
    Mallinckrodt Plc
    MNK US
    54,087
    2,926,6480.97
    Gw Pharmaceuticals Plc
    GWPH US
    12,111
    1,567,5270.52
    Akorn Inc
    AKRX US
    59,208
    1,297,2470.43
    Endo International Plc
    ENDP US
    86,683
    1,143,3490.38
    Other/Cash
    --
    --
    -170,260-0.06
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.